HealthEquity, Inc.
HQY Healthcare Health Information Services
HealthEquity, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $1.3 billion, up 9.47% from fiscal 2025.
- Revenue
- +7.64%
- EPS
- +14.5%
- Free cash flow
- −3.44%
- Total debt
- −7.53%
Quarter to July 2026, against a year earlier
Follow HQY
Alert me
HealthEquity, Inc. (HQY) P/E ratio
As of 5 November 2026, HealthEquity, Inc. (HQY) trades at a P/E ratio of 36.9×. Over the past ten years it has ranged from 0.0× (July 2023) to 7,417× (August 2021); the current reading is higher than 23% of that period. That is below the Health Information Services industry median of 42.0× and above the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2026 | 35.0× | (64.85%) |
| FY2025 | 99.5× | (14.45%) |
| FY2024 | 116× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 711× | 620.70% |
| FY2020 | 98.6× | 88.21% |
| FY2019 | 52.4× | (19.28%) |
| FY2018 | 64.9× | (36.86%) |
| FY2017 | 103× | 40.13% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jul 2026 | 36.1× | 18.25% |
| Apr 2026 | 30.5× | (12.79%) |
| Jan 2026 | 35.0× | (18.29%) |
| Oct 2025 | 42.8× | (25.88%) |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| TEM Tempus AI, Inc. compare | n/m |
| HTFL Heartflow, Inc. compare | n/m |
| SDGR Schrodinger, Inc. compare | n/m |
| BTSG BrightSpring Health Services, Inc. compare | 33.0× |
| HQY HealthEquity, Inc. | 36.9× |
| WAY Waystar Holding Corp. compare | 40.9× |
| DOCS Doximity, Inc. compare | 44.4× |
| HNGE Hinge Health Inc. compare | 86.1× |
| PRVA Privia Health Group, Inc. compare | 88.3× |
| Health Information Services industry median | 42.0× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on HQY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement